192 related articles for article (PubMed ID: 29369166)
41. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
42. Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV.
deFilippi C; Christenson R; Joyce J; Park EA; Wu A; Fitch KV; Looby SE; Lu MT; Hoffmann U; Grinspoon SK; Lo J
J Acquir Immune Defic Syndr; 2018 May; 78(1):105-110. PubMed ID: 29419569
[TBL] [Abstract][Full Text] [Related]
43. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
Nicholls SJ; Ray KK; Ballantyne CM; Beacham LA; Miller DL; Ruotolo G; Nissen SE; Riesmeyer JS;
Atherosclerosis; 2017 Jun; 261():12-18. PubMed ID: 28412650
[TBL] [Abstract][Full Text] [Related]
44. Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: A multicenter prospective study.
Li Z; Hou Z; Yin W; Liu K; Gao Y; Xu H; Yu F; Ma Z; Yu W; Yang L; Lu B
Am Heart J; 2016 Oct; 180():29-38. PubMed ID: 27659880
[TBL] [Abstract][Full Text] [Related]
45. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.
Hileman CO; Turner R; Funderburg NT; Semba RD; McComsey GA
AIDS; 2016 Jan; 30(1):65-73. PubMed ID: 26731754
[TBL] [Abstract][Full Text] [Related]
46. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
[TBL] [Abstract][Full Text] [Related]
47. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy.
Takano M; Mizuno K; Yokoyama S; Seimiya K; Ishibashi F; Okamatsu K; Uemura R
J Am Coll Cardiol; 2003 Aug; 42(4):680-6. PubMed ID: 12932601
[TBL] [Abstract][Full Text] [Related]
48. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
49. Effect of Ezetimibe on Stabilization and Regression of Intracoronary Plaque - The ZIPANGU Study.
Ueda Y; Hiro T; Hirayama A; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
Circ J; 2017 Oct; 81(11):1611-1619. PubMed ID: 28592751
[TBL] [Abstract][Full Text] [Related]
50. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
51. Effect of torcetrapib on the progression of coronary atherosclerosis.
Nissen SE; Tardif JC; Nicholls SJ; Revkin JH; Shear CL; Duggan WT; Ruzyllo W; Bachinsky WB; Lasala GP; Tuzcu EM;
N Engl J Med; 2007 Mar; 356(13):1304-16. PubMed ID: 17387129
[TBL] [Abstract][Full Text] [Related]
52. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
53. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.
Arad Y; Spadaro LA; Roth M; Newstein D; Guerci AD
J Am Coll Cardiol; 2005 Jul; 46(1):166-72. PubMed ID: 15992652
[TBL] [Abstract][Full Text] [Related]
54. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
[TBL] [Abstract][Full Text] [Related]
55. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
[TBL] [Abstract][Full Text] [Related]
56. The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy.
Madonna R; Renna FV; Lanuti P; Perfetti M; Marchisio M; Briguori C; Condorelli G; Manzoli L; De Caterina R
PLoS One; 2017; 12(4):e0172800. PubMed ID: 28394933
[TBL] [Abstract][Full Text] [Related]
57. Effect of Evolocumab on Coronary Plaque Composition.
Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJP; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Honda S; Shishikura D; Scherer DJ; Borgman M; Brennan DM; Wolski K; Nissen SE
J Am Coll Cardiol; 2018 Oct; 72(17):2012-2021. PubMed ID: 30336824
[TBL] [Abstract][Full Text] [Related]
58. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
59. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
[TBL] [Abstract][Full Text] [Related]
60. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy.
Kwon O; Kang SJ; Kang SH; Lee PH; Yun SC; Ahn JM; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Park SW; Park SJ
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
